2021 SEP 17 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - From Washington, D.C., NewsRx journalists report that a patent application by the inventors Ng, Boon Khai (La Crescenta, CA, US); Schmidt, Siegmar (Simi Valley, CA, US), filed on May 5, 2021, was made available online on September 2, 2021. The patent's assignee is Alfred E. Mann Foundation for Scientific Research (Valencia, California, United States). News editors obtained the following quote from the background information supplied by the inventors: "Obstructive sleep apnea (OSA) is a common disorder in which the upper airway of a patient can become obstructed (apnea) or partially obstructed (hypopnea) during sleep. It is highly prevalent, affecting 5%-10% of the adult population in the United States, and has serious effects and comorbidities, such as daytime sleepiness, snoring, poor sleep quality, and an increased risk of cardiovascular disease and motor vehicle accidents. Conventional treatments of OSA include using continuous positive airway pressure (CPAP) techniques or performing upper airway surgery. However, due to discomfort, CPAP has a low adherence rate over time, thereby limiting its effectiveness. Alternatively, upper airway surgery is painful and requires a prolonged recovery period, and therefore is used as a last resort to the treatment of OSA, reserved for only extreme cases.
展开▼
